← Back to feedRead original →
VERIFIEDMint Companies·positive
Biosimilar ramp-up to drive growth for Biocon in FY27
AI Summary
- ·Biocon's recently launched biosimilars are scaling up across markets.
- ·This ramp-up is expected to gather momentum throughout the year.
- ·The growth is particularly anticipated in the second half of FY27.